We are live on ! Find out more
NSRI

New Silk Road Investment Portfolio holdings

AUM $50.4M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+14.88%
1 Year Est. Return
+32.31%
3 Year Est. Return
-21.21%
5 Year Est. Return
+10.41%
10 Year Est. Return
AUM
$191M
AUM Growth
+$31.7M
Cap. Flow
+$3.46M
Cap. Flow %
1.81%
Top 10 Hldgs %
100%
Holding
10
New
3
Increased
Reduced
3
Closed
1

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$18.8M
2
EDU icon
New Oriental
EDU
+$3.01M
3
TCOM icon
Trip.com Group
TCOM
+$2.27M
4
INFY icon
Infosys
INFY
+$506K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 74.12%
2 Financials 13.49%
3 Consumer Staples 2.05%
4 Technology 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$289B
$132M 68.73%
761,482
-115,745
-13% -$18.8M
HDB icon
2
HDFC Bank
HDB
$123B
$25.8M 13.49%
1,071,200
CBPO
3
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$17.5M 9.13%
+189,395
New +$18.2M
MMYT icon
4
MakeMyTrip
MMYT
$5.32B
$7.3M 3.81%
+253,891
New +$8.12M
TTM
5
DELISTED
Tata Motors Limited
TTM
$3.01M 1.57%
96,271
EDU icon
6
New Oriental
EDU
$9.38B
$2.47M 1.29%
28,000
-36,900
-57% -$3.01M
INFY icon
7
Infosys
INFY
$48.4B
$1.77M 0.92%
242,200
-66,800
-22% -$506K
VSA
8
VisionSys AI
VSA
$8.07M
$1.45M 0.76%
+40
New +$1.68M
GSUM
9
DELISTED
Gridsum Holding Inc.
GSUM
$552K 0.29%
53,600
TCOM icon
10
Trip.com Group
TCOM
$29.5B
-42,151
Closed -$2.27M

Similar funds

New Silk Road Investment's Q3 2017 Portfolio in Review

As of Q3 2017, New Silk Road Investment held 10 positions worth $191M, up 20% from $160M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

New Silk Road Investment's Q3 2017 filing shows 3 new, 3 reduced and 1 closed positions. Its largest new stake was China Biologic Products Holdings, Inc.: 189,395 shares worth $17.5M. The largest sale was Alibaba, an estimated $18.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 74% of assets, down from 81% a quarter earlier, followed by Financials and Consumer Staples.

  • New Silk Road Investment's largest Q3 2017 buy was China Biologic Products Holdings, Inc.: 189,395 shares worth $17.5M.
  • New Silk Road Investment's biggest Q3 2017 reduction was Alibaba, cutting an estimated $18.8M.
  • New Silk Road Investment fully exited Trip.com Group in Q3 2017, selling an estimated $2.27M.
  • New Silk Road Investment's ten largest holdings make up 100% of its $191M portfolio in Q3 2017.
  • New Silk Road Investment opened 3 new positions and closed 1 in Q3 2017.
  • New Silk Road Investment's portfolio value rose 20% quarter-over-quarter to $191M.

Based on New Silk Road Investment's 13F filing for Q3 2017, filed 17 Oct 2017.